- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
71 Cards in this Set
- Front
- Back
|
Immune System Basics
|
*Function of the Immune System:
-Defense-against microorganisms, prevents infection by destroying them -Surveillance-protection from internal invaders, i.e., malignant cells -Homeostasis-provides the body with clean up operations (removes dead and damaged cells-mutations) |
|
Major Features of the Immune System
|
*Specificity: able to discriminate various antigens or other invaders
*Diversity: has extensive number of receptors to recognize invaders *Memory-able to mount long lasting reactions to antigens *Self-vs-self recognition-autoimmune disease occurs if this breaks down (body attacks own tissues) |
|
General Primary (Central) Lymphoid Organs
|
*Thymus: central lymphoid organ in mediastinal area above heart, responsible for differentiation and maturation of T-lymphocytes
*Bone Marrow: undifferentiated stem cells originate here and mature before entering circulation |
|
Peripheral (Secondary) Lymphoid Organs
|
*Lymph nodes: part of lymphatic system, filters foreign particles, ex. bacteria
*Spleen: largest single collection of lymphocytes, largest filter of foreign tissue *Liver: filters foreign tissue from blood *Tonsils: lymphoid tissue *Peyer's Patches: lymphoid tissue that lines wall of ileum, has macrophages |
|
Immunity
|
Immunity
-Innate (inborn) genetic factors -Acquired 1. Active (own antibodies) -Natural (exposure to infectious agent) -Artificial (immunization) 2. Passive (ready-made antibodies) -Natural (maternal antibodies) -Artificial (antibodies from other sources) |
|
Location of lymph nodes and lymph organs
|
Tonsils and adenoids
Lymph nodes Thymus Spleen Peyer's Patches Appendix Bone Marrow Appendix |
|
Types of Immunity
|
*Humoral: B-lymphocyte mediated, responsible for antibody (immuneglobulin) production antibody-mediated immunity.
*Antibodies, dissolved in blood, lymph, and other body fluids bind the antigen and trigger a response to it. (This form of immunity is also called humoral immunity.) |
|
Types of Immunity
|
*Cell-mediated immunity (CMI) T cells (lymphocytes) bind to the surface of other cells that display the antigen and trigger a response. The response may involve
*other lymphocytes and *any of the other white blood cells (leukocytes) |
|
Disorders of the Immune System
|
*Immunodeficiency disorders: incompetent immune system: SCIDS (severe combined immunodeficiency syndrome no T cells or B lymphocytes), AIDS
*Hypersensitivity disorders: allergic reaction, anaphylaxis *Autoimmune disorders: body doesn't recognize self as self -rheumatoid arthritis, MS, Lupus, diabetes |
|
Introduction to HIV/AIDS
|
*Human Immunodeficiency Virus (HIV)
*Discovered in 1983 *No longer considered a death sentence but a chronic disease -Communicable via blood and body fluids: cerebral spinal fluid, semen, vaginal secretions and breast milk -Will eventually lead to AIDS -Occurs as HIV1 (95% of US cases) -HIV2 (most prevalent in West Africa) |
|
Incidence and Epidemiology
|
*21st Century Plague - since 1981 worldwide: 58 million people infected with 22 million dying from AIDS
*A disease of disenfranchised by gender, race, sexual orientation, poverty and access to health care *2005 - 1 million infected in US |
|
Adults and children estimated to be living with HIV/AIDS as of end 2003
|
Total: 34-46 million
|
|
The most common methods of transmission of HIV are:
|
-Unprotected sex with an infected partner
-Sharing needles with infected person |
|
Almost eliminated as risk factors for HIV transmission are:
|
-Transmission from infected mother to fetus
-Infection from blood products (in the US 1 in 12,000,000) |
|
Methods of Transmission
|
*Sexual transmission - most common
*Blood and blood products - needle sticks, IV drug abuse, potentially transmitted via transfusion *Pregnancy and delivery *Breast milk |
|
Factors that Effect Transmission
|
*Viral load
*Susceptible Host (ex: Hep B or C) *Virulence of the virus *Concentration of the virus (viral load) *Frequency of contact *Volume of fluid *Depth of wound *.3-.4% risk for health care workers |
|
Transmission
|
*Extremely fragile virus - hard to keep alive
*Probability of infection is based on: -concentration and strain of virus -amount of fluid transmitted -duration and frequency of exposure as well as host immune system |
|
Risk Factors: Sexual Practices
|
*Unprotected Sex (most common mode of transmission)
*Multiple partners *Anal and oral sexual activities *Improper condom use/breakage *Open sores, lesions, infections in genital area |
|
Risk Factors: Contaminated Blood and Blood Products
|
*Minute possibility in US for transfusion related transmission-all blood and blood products screened
*Only 20% of world's blood screened *Health care workers *Correctional officers and law enforcement personnel *IV drug abuse, sharing of syringes and drug equipment |
|
Risk Factors: Pregnancy and Breast Feeding
|
*Approximately 120,000 to 160,000 women living in US with HIV infection
*6,000 to 7,000 infected women give birth each year in US *600,000 babies contract HIV worldwide each year *Breastfeeding not advised |
|
Pathophysiology of HIV
|
*Classified as retrovirus, can't make copies of itself on its' own
*Must invade healthy T cell (CD4) in host *Has a special chemical to allow entrance into CD4 cell *Releases enzyme reverse transcriptase to convert HIV RNA to DNA |
|
Pathophysiology
|
*Inside cell nucleus the DNA replicates the HIV virus using protease
*New copies of virus formed, cell dies *Up to 10 billion HIV particles produced daily *Over 2 billion new CD4 cells needed to keep up, not possible for body to do |
|
Pathophysiology
|
*Inside CD4, HIV uses 3 enzymes to replicate itself:
-Reverse transcriptase -Integrase -Protease *Treatment based on interfering with enzyme activity, thus preventing replication |
|
Pathophysiology
|
*Consequences
-All daughter cells from infected cell are infected -Genetic codes can direct the cell to make HIV |
|
Nursing Management
Nursing Assessment |
*For persons at risk, ask
-Have you had a sexual experience with your penis, vagina, rectum, or mouth in contact with these areas of another person? -Have you ever had a sexually transmitted disease (STD)? -Have you ever shared (equipment) needles with anyone? |
|
Diagnostic Tests for HIV
|
*ELISA (Enzyme-linked immunosorbent assay) most common, confirms presence of HIV antibodies
*Western Blot can identify 1 protein in a mixture of many proteins (looks at antibody classes) more specific *IFA (Immunofluorescence Assay) tests for p17 and p24 antigen found on HIV (looks at infected cells) **POSITIVE ELISA, NEED TO HAVE A WESTERN BLOT TO CONFIRM DIAGNOSIS** |
|
Newer Diagnostic Tests
|
*Ora-Sure - Saliva test, approved March, 2004
*Mouth is swabbed, if turns red = positive (confirmed by blood test) *Home access test - FDA approved, but sample must be sent back to company |
|
Diagnostic Testing for HIV
|
*Both ELISA and Western Blot depend on antibody formation
*About 90% of people exposed to HIV will develop antibodies in 6 weeks to 3 months following exposure; it may be as long as 6 months to 1 year *IFA tests for specific protein "Window period"" 6 wks to 1 year HIV infected but have not developed antibodies yet |
|
Spectrum of HIV Infection
|
*Viral transmission with Primary HIV infection
*Seroconversion with antibodies *Asymptomatic chronic infection *Symptomatic HIV infection *AIDS - based on CDC definition *Advanced HIV disease CD4 <50 |
|
Spectrum of HIV Infection
|
*ACUTE INFECTION: process of seroconversion (often mistaken for mononucleosis) "flu-like" symptoms acute retroviral syndrome
*May last days to months *Known as the "WINDOW" period, infectious without antibodies until seroconversion takes place *Occurs 1-3 weeks post exposure (high viral load in blood) |
|
Spectrum of HIV Infection
|
*SEROCONVERSION
*Majority of those exposed develop antibodies within 3 months *May take up to a year in small percentage of people *Body produces antibodies to the HIV virus |
|
Spectrum of HIV Infection
|
*EARLY CHRONIC INFECTION: May last up to 10 years "asymptomatic disease"
*None to minimal symptoms: fatigue, anemia, night sweats, persistent generalized lymphadenopathy *CD4 counts remain above 500 cells/mm (persistent level) |
|
Spectrum of HIV Infection
|
*INTERMEDIATE CHRONIC INFECTION: More severe symptoms, CD4 count drop to 200-500 cells/mm
*Viral load increases *More evidence of disease progression with opportunistic diseases: Kaposi's Sarcoma (KS), candida (thrush), shingles, hairy leukoplakia (raised white lesions on tongue) |
|
Spectrum of HIV Infection
|
*LATE CHRONIC INFECTION (AIDS): Diagnosis of AIDS not made until CDC criteria met
*CD4 count declines <200 cells/mm *Presence of Ol's wasting syndrome with >10% weight loss *Malignancies and dementia common |
|
Spectrum of HIV Infection
|
*ADVANCED HIV DISEASE OR END STAGE HIV DISEASE: CD4 count <50
*Overwhelming opportunistic infections and diseases that resist treatment *Period preceding death from AIDS (weeks to months) |
|
HIV Versus AIDS
|
*CDC classification for AIDS diagnosis:
1. CD4 count <200 2. Presence of Opportunistic Infection 3. Development of opportunistic cancers A. Invasive cervical cancer (HPV) B. Kaposi's sarcoma (KS) C. Burkitt's lymphoma 4. Wasting Syndrome 5. dementia |
|
Opportunistic Infections and Diseases
|
*FUNGAL: candidiasis of respiratory tract, Pneumocystis carinii pneumonia (PCP)-treated with bactrim
*VIRAL: cytomegalovirus (CMV) retinitis - loss of vision, herpes simplex - chronic *PROTOZOAL: toxoplasmosis of the brain *BACTERIAL: Mycobacterium tuberculosis, Salmonella septicemia |
|
Opportunistic Infections and Diseases
|
*MALIGNANCIES OFTEN SEEN:
-AIDS associated lymphomas -Invasive cervical cancer -Kaposi's sarcoma |
|
Clinical Manifestations of HIV
|
*Chills and fever
*Night sweats *Productive cough *Dyspnea *Lethargy/fatigue *Confusion *Stiff neck *Headache *Diarrhea *Persistant vaginal candida *Oral candida *Oral lesions *Abdominal pain *Weight loss *Neuropathies *Lymphadenopathy *Skin rash |
|
Effects on Body Systems
|
*PULMONARY SYSTEM
*Often first manifestation of HIV infection *TB in HIV infection global problem *Pneumocystis carinii pneumonia (PCP) common Ol *Has both prophylaxis and treatment: Trimethoprin-sulfamethoxazole (Bactrim) |
|
Effects on Body Systems
|
*GASTROINTESTINAL SYSTEM
*Cryptosporidium (parasite) most widely recognized pathogen in AIDS infection *Causes massive diarrhea (dehydration) *Candida may be first sign of suppressed immune system, can affect entire GI tract mouth to anus |
|
Effects on Body Systems
|
*NERVOUS SYSTEM
*HIV crosses blood-brain barrier *Can cause encephalopathy with loss of cognitive and motor function *Peripheral neuropathy is common *CNS lymphoma-resistant to treatment (brain tumor associated with impending death) *AIDS Dementia Complex (ADC) confussion, agitation whole spectrum of mental status changes |
|
Effects on Body Systems
|
INTEGUMENTARY SYSTEM
*Kaposi's sarcoma - common in men, aggressive in HIV disease (lungs, oral mucosa, entire GI tract) *Herpes zoster-resistant to treatment *Rashes - seborrheic dermatitis psoriasis |
|
Effects on Body Systems
|
*HEMATOLOGIC SYSTEM:
*Anemia, thrombocytopenia and neutropenia due to decreased blood production and increased lymphocyte destruction *Body not able to keep up with losses *Medications can be immunosuppressive |
|
Effects on Body Systems
|
*GYNECOLOGICAL SYSTEM
*Vaginal candida may be first sign of HIV disease in women *Human papilloma virus (HPV) *Cervical dysplasia *Cervical cancer |
|
Effects on Body Systems
|
*CARDIOVASCULAR - OI of pericardium (OI = opportunistic infection)
*MUSCULOSKELETAL - arthralgias, weakness *RENAL - renal failure *ENDOCRINE - risk of diabetes with HIV medications (antiviral drugs) *SENSORY - CMV retinitis, neuropathies |
|
Determining Immune Damage
|
*CD4 and T cell counts are measured to determine extent of immune damage
*Viral load determines "viral burden" or amount of virus particles per mL of blood *Both should be measured at diagnosis and routinely after - depends on client and treatment |
|
Management of HIV/AIDS
|
*There is no cure for AIDS
*Current medical management is: -Treating/preventing infections -Treating malignancies -Administration of medications that block or inhibit replication |
|
HAART (Highly Active Antiretroviral Therapy)
|
*1. HIV fusion inhibitors (inhibit HIV from binding on CD4 cell)
*2. Reverse transcriptase inhibitors -Nucleoside reverse transcriptase inhibitors (NRTI) -Non-nucleoside reverse transcriptase inhibitors (NNRTI) (prevent RNA-DNA conversion *3. Protease inhibitors ALL DRUGS DECREASE REPLICATION WHICH IN TURN DECREASES VIRAL LOAD |
|
Examples of HAART
|
*NRTI: Zidovudine (AZT), Stavudine (Zerit)
*NNRT: Efavirenz (Sustiva), Nevirapine (Viramune) *Fusion Inhibitor: Enfuvirtide (Fuzeon) (BID Subcutaneous very expensive) |
|
Goals of Antiretroviral Therapy
|
*Maximal HIV suppression
*Undetectable viral load (<50 copies) *Effective combination therapy (3 agents) *Select tolerable regimen *Individualize treatment *Educate client *Assure adherence *Consider viral genotyping *Prevent development of viral resistance *Maintain or raise CD4 T cell counts to >200 *Reduce HIV related morbidity & mortality *Improve quality of life |
|
Assuring HAART Compliance
|
*Probably most difficult aspect of HAART therapy (30,40,50,60 drugs/day)
*Missed dose(s) lead to viral replication and resistance *Eventually no adequate treatment left due to multi-drug resistance |
|
Assuring HAART Effectiveness
|
*3 classes of antiretrovirals used
*May be as many as 60 pills per day *Must be taken at specific times, with and without food *Prescribed at full strength *Potentially lethal side effects when combined with OTC and herbal therapy |
|
Complications and Long-term Effects of HAART
|
*Lipodystrophy and lipoatrophy
*Development of Type II Diabetes (protease inhibitors) *Hyperlipidemia *Resistance *Nausea/vomiting/diarrhea *Neuropathies *Osteonecrosis and osteoporosis *Cardiomyopathy *Hepatic Steatosis *Myelosuppression *Lactic Acidosis |
|
Lipodystrophy and Lipoatrophy (Loss of facial fat tissue)
|
*Complication of long term HAART
*Affects Caucasian men over 40 who had HIV infection >7 years *Affects those with higher viral load *AZT (NRTI) and protease inhibitors are implicated *Cause still not known, just suspected |
|
Diabetes Mellitus
|
*HAART in HIV positive population raises risk of diabetes by nearly 2-3 times over non HIV infected males
*No single drug implicated, cause not known *HAART therapy changes glucose metabolism, raises blood sugars |
|
Hyperlipidemia
|
*Elevated cholesterol and triglycerides increase risk of heart attack, stroke and PVD
*More HIV infected clients dying from side effects of medications - rather than from AIDS |
|
Resistance
|
*High rate of virus mutation with drug resistance
*The earlier resistance occurs, the more likely treatment will fail *Resistance is one reason it's important to continue developing new drugs *Research to develop a vaccine against resistance |
|
Complications, continued
|
*Nausea/vomiting/diarrhea
*Neuropathies *Osteonecrosis and osteoporosis *Cardiomyopathy *Hepatic Steotosis |
|
Evaluation of Treatment
|
*Measure viral load-goal is for undetectable level-client still infectious <50 copies
*Measure CD4 count *Monitor CBC, LFT's, amylase, lipids, cholesterol and glucose |
|
Deciding to Treat or Not
|
*Cost: up to $12,000/year in MA
*Pill burden and adherence *End of life issues *Planned pregnancies *Aging issues *Substance abuse issues |
|
HIV Disease Stages and CD4 Count
|
STAGE: ACUTE RETROVIRAL INFECTION
CD4 CELL/mm = 750-1000 STAGE: ASYMPTOMATIC HIV/EARLY CD4 CELL/mm = 500-750 STAGE: INTERMEDIATE CD4 CELL/mm = <500 STAGE: LATE CD4 CELL/mm = <200 = AIDS STAGE: ADVANCED HIV CD4 CELL/mm = <50 |
|
Nursing Diagnosis
|
**See Handout**
|
|
Nursing Interventions
|
*Smoking education
*Teach relaxation and stress reduction *Encourage routine exercise *Nutritional education *Infection control guidelines *Avoid all animal droppings/cat litter, etc. *Teach safe/safer sex |
|
Health Promotion
|
*Prevention of HIV
-Decreasing risks related to: Sexual intercourse Drug use Perinatal transmission Work |
|
Health Promotion
|
*Prevention of HIV
-Decreasing risks related to sexual intercourse *Abstinence *Outercourse |
|
Health Promotion
|
*Prevention of HIV
-Decreasing risks related to sexual intercourse *Use barriers (e.g., condoms) when engaging in insertive sexual activity |
|
Health Promotion
|
*Prevention of HIV
-Decreasing risks related to drug use *Do not use drugs *Do not share equipment *Do not have sexual intercourse when under the influence of any drug (including alcohol) that impairs decision making ability |
|
Health Promotion
|
*Prevention of HIV
-Decreasing risks related to perinatal transmission *Prevent HIV infection in women *Treat HIV pregnant women with zidovudine (ZDV, AZT, Retrovir) *Combination ART for the mother's HIV infection can decrease transmission to fetus to less than 2% *Viral load >1000 = C Section |
|
Health Promotion
|
*Prevention of HIV
-Decreasing risks related to work *Greatest risk is through puncture wounds *Splash exposure of blood on skin with open lesion present some risk, though much lower than puncture *Exposure to HIV-infected fluids require post-exposure prophylaxis with combination ART (2-3 drugs for 4 weeks - trying to prevent seroconversion) |
|
Current Trends
|
*CDC will soon recommend every American aged 13-64 to have HIV testing as part of routine exam
*? Vaccine to prevent or slow progression of HIV within a decade (Dr. Tony Fauci, NIH) *Darunavir - accelerated approval by FDA as a new protease inhibitor for clients with resistance to other protease inhibitors |